SIA
MRNA icon

SkyView Investment Advisors’s Moderna MRNA Stock Holding History

SkyView Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-22
Closed -$2K – 368
2023
Q3 		$2K Buy
+22
New +$2.45K ﹤0.01% 479
2023
Q2 		– Sell
-4
Closed -$1K – 813
2023
Q1 		$1K Buy
+4
New +$660 ﹤0.01% 620

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SkyView Investment Advisors's MRNA Position: Q4 2023 in Review

SkyView Investment Advisors sold out of Moderna (MRNA) in Q4 2023, closing a stake of 22 shares — an estimated $2K sold.

SkyView Investment Advisors first reported a position in MRNA in Q1 2023 and held it in 2 quarters. The position peaked at $2K in Q3 2023. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • SkyView Investment Advisors reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • SkyView Investment Advisors sold 22 Moderna shares in Q4 2023, an estimated $2K.
  • SkyView Investment Advisors first reported a position in Moderna in Q1 2023 and held it in 2 quarters.
  • SkyView Investment Advisors's Moderna position peaked at $2K in Q3 2023.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on SkyView Investment Advisors's 13F filing for Q4 2023, filed 15 Feb 2024.